The Association of Clinical Research Professionals
ACRP Board of Trustees
CHAIR Kathryn L. Kimmel, CCRC, CCRA, FACRP, ACRP-CP decided to explore opportunities in clinical research after working 15 years in a hospital based laboratory. In the 22 years Kathryn has been in the clinical research field, she has worked as a CRC, a director of a multi-therapeutic clinic based research department, a CRA and a Regional Manager of CRAs. Kathryn has also served as Chair for the Phlebotomy exam for NCA, and a committee member and Chair of the ACRP Global CCRC Exam Committee. Kathryn has served as a Board member and Chair of the Academy Board of Trustees and ABoT Liaison to the Academy Board. She has also served at Chair of the ACRP Governance Committee and member of the ACRP Nominating Committee. Kathryn has been active with ACRP at the local level, was a charter member and served as President and Program Chair of the Inland Northwest Chapter (now disbanded). Kathryn has maintained her ACRP certifications for both CRC (20 years) and CRA (13 years) and is very passionate about certification and the value it brings to the industry. Kathryn is currently a Senior Clinical Research Associate with PRA Health Sciences. She served as ACRP’s 2017 Vice Chair of the Board of Trustees.
John Neal CPA (inactive), BS, CRCP is Founder and Chairman of PCRS Network, LLC, an international network of quality focused, independent clinical research sites that conduct phase I through IV studies in a broad range of indications. John received his Bachelor of Science degree in Accounting, graduating with honors, from San Diego State University. He became a Certified Public Accountant in the State of California while working with Deloitte & Touche, serving privately held and venture capital backed high-tech, early stage biotech, and pharmaceutical companies. John has held executive positions with several clinical research sites, and provides strategic direction to his clients. He has founded several companies and a not-for-profit organization, and has served on the Board of Directors of numerous companies and organizations. He served on the Board of Directors of the California Chamber of Commerce for fourteen years, and was the Chairman of its Small Business Committee. John served on the committee to reactivate the ACRP Site Interest Group in the Online Community and lead a solutions focused discussion between Sponsors, CROs, and Sites at the 2nd Annual Site Strategy Forum in April 2015. He is a frequent speaker at clinical research conferences, has authored a variety of articles on clinical research financial and management topics (including an article in The Monitor, September 2010), and is a frequent contributor to clinical research forums online. John is an enthusiastic supporter of ACRP and is dedicated to accelerating clinical research through innovation and best practices. John served as the 2017 Treasurer of ACRP’s Board of Trustees and Chair of the ACRP Finance Committee.
IMMEDIATE PAST CHAIR Jeff K. Kingsley, DO, MBA, CPI, FACRP is founder and CEO of IACT Health, a research management organization, and ten wholly owned and integrated clinical research offices throughout Georgia. This family of companies conduct phase I through IV research in nearly every medical specialty. His medical degree was received from the Philadelphia College of Osteopathic Medicine in 2001 and he completed his MBA from Emory University’s Goizueta Business School in 2011. Following medical school, Jeff completed residency training in Family Medicine with the Columbus Regional Healthcare System and was hired as academic faculty immediately upon graduation. He has been director of several departments and holds faculty positions with Mercer School of Medicine and Georgia Regents University. Additionally, Jeff has been President of an international non-profit organization, has two board seats, and served as the 2017 Chair and the 2016 Vice Chair of the ACRP Board of Trustees.
TREASURER Erika Stevens, MA is Vice President for Research at Northwell Health where she leads research programs, integrity, operations and administration. Prior to joining Northwell, Ms. Stevens led research transformation advisory services for seven years in management consulting firms. Ms. Stevens has over 20 years of research experience, including over 12 years in research management serving in roles such as Senior Managing Director, Director Clinical Trials Office, Director of Clinical Research, Interim Executive Director, Clinical Trials Office and Director of Research Operations. Ms. Stevens is the immediate past president of the Association of Clinical Research Professionals (ACRP) New York Metropolitan Chapter. Ms. Stevens served as chair, for two terms, of the editorial advisory board for “The Clinical Researcher,” the peer reviewed journal publication for Association of Clinical Research Professionals (ACRP). Ms. Stevens is an ACRP Board of Trustees member. She is also a frequent speaker on research operations and compliance practices at national conferences. Additionally, she is a published author whose work appears in a variety of peer journals including the American Journal of Obstetrics & Gynecology, The Monitor, Clinical Researcher, Regulatory Focus, Applied Clinical Trials, Clinical and Translation Science and the Journal of Mental Health and Aging. Erika serves on the Nomination Committee and is the immediate past president of the New York Metropolitan Chapter.
Guy Iannuzzi, CEO, Mentus is a marketing executive with over 45 years of experience in marketing biotech and high technologies. He and Mentus have become proficient in translating technology innovation into commercial success in a wide range of industries and markets – useful in helping fund 150 IPOs. Guy founded Mentus in 1981, to market high technology and biotech for companies and institutions such as the DOD, DOE, NIH, the NSF (He was a founding director of San Diego’s Biocom). Leveraging a national reputation for developing creative promotional platforms for innovation, Mentus provides marketing and investor communications for emerging technology and FORTUNE 500 companies. Guy’s four decades of corporate marketing includes being general manager of Marina Advertising, the marketing division of Revell in Los Angeles. He has held creative and marketing positions with the Summa Corporation, the Getty Oil Corporation, Lockheed Electronics and Young & Rubicam. He has also marketed high technology in Europe, Latin America and the Middle East. Versed in marketing and finance issues in a wide range of industries, Guy is able to motivate management teams to achieve extraordinary results in challenging environments and disparate cultures via seminars and workshops on market positioning and messaging. He also makes numerous presentations on best practices for marketing innovative technologies and market positioning. Currently, Guy is involved in promoting the San Diego transformation as a biotech and high tech cluster around the world. He is also developing and implementing medical tourism programs for destinations across the U.S
Anne Blanchard, CCRA is CEO and Director of Clinical Operations for a regional Contract Research Organization operating in Latin America, leading numerous projects ongoing in Argentina, Brazil, Chile, Mexico and Colombia since November 2008. She began her career in Clinical Research in 1997, when she worked for a multi-national CRO in Argentina. Since then Anne has been involved in Clinical Monitoring and Management for both the Biopharmaceutical & Medical Device Industry and Academic Based Research. Anne studied Biology at the University of Buenos Aires and completed her postgraduate in Monitoring of Clinical Trials and in Clinical Research in the AMA (Argentine Medical Association) in 2001. Internationally ICH certified as CRA by ACRP in 2004, and presently Item Writer for the CCRA exam, Anne is also Editor of the Barnett International GCP Question and Answer Guide (Section for Latin America) yearly since 2012. Anne has authored several articles in publications such as The Monitor and GCP Journal, presented in several international conferences and also hosted webinars related to the implementation of Clinical Research studies, regulations and oversight for compliance in Latin America. In 2015 she won the Outstanding Leadership in Clinical Research as a CRA Award by ACRP. She is also presently a member of the board within The Association of International CROs, AICROS, where she is responsible to cover Latin America. Since 2005, Anne is also president of Fundacion Dra. Cecilia Grierson, a regional not-for-profit organization dedicated to inform the community in general about the process for participation in research and education to clinical research professionals about regulations and research administration.
Jennifer Byrne is the Founder and President of Greater Gift (501(c)3). Through Greater Gift, nearly 80,000 vaccines have been donated in honor of clinical trial participants to children in need in developing countries. Each vaccine recognizes expresses gratitude for the medical heroism of a trial volunteer or life science individual who is advancing health advancement locally to affect global impact…. one child at a time. Formerly, Jennifer was the Chief Executive Officer of PMG Research, Inc. (PMG). During Jennifer’s 25 year tenure, PMG conducted over 7500 clinical trials with the inclusion of 150,000 trial participants across the development of hundreds of compounds, and medical devices. Jennifer and her team established PMG Research as a market leader and also as a health care institution partner of choice. With her leadership, PMG Research transitioned successfully to both a private equity partner, Frontier Capital, and in December of 2015 to a global Contract Research Organization, ICON plc. Jennifer is highly committed to building better bridges between patients and their health care providers to the life science community. Strategically, Jennifer is committed to help lead the transformation of clinical research as a care option for all patients within their natural continuum of care and to work within the ecosystem to drive more value through the improvement of the clinical trials enterprise. Jennifer was recognized as a CenterWatch Top 25 Innovator and currently serves as an Advisory Board member to CISCRP, the Wake Forest Institute of Regenerative Medicine, and Advisory Committee Member for NC Biotech Piedmont Triad. She is also a Board Member of the Hospice Foundation and Summit School. Jennifer earned her bachelor of science in Nutrition at Texas A&M University.
Elisa Cascade, MBA has over 25 years of experience in strategy consulting, pharmaceutical clinical research, market research, brand strategy, salesforce deployment, health economics, and pricing. Her industry honors include being named to the 2016 PharmaVOICE 100 and the 2017 Medicine Maker Power 100 for her innovative approach to furthering clinical research through industry collaboration and standardization of clinical trial technology/processes. As Chief Product Officer at DrugDev, a technology company with a suite of investigator-facing solutions, Elisa is responsible for DrugDev’s platform solutions that are used by individual pharmaceutical companies and CROs, and industry collaborations including the Investigator Databank and TransCelerate Investigator Registry. Prior to DrugDev, Elisa was a Vice President at Quintiles where she ran global operations for Quintiles Digital Patient Unit with responsibility for direct-to-patient studies. She also performed strategic consulting for the Lewin Group. Elisa has a substantial track record of publications and presentations across a variety of research topics including writing and disseminating results of the DrugDev Annual Investigator Survey as well as publishing a regular “Pulse on Technology” column in CenterWatch Monthly. Elisa has an MBA from The Wharton School and a B.S. with High Honors and High Distinction from the University of Michigan.
Paul Evans, PhD has worked in the pharmaceutical industry for over 25 years. He is currently Corporate Vice President, Global Site Solutions at PAREXEL where he has been for the past 4 years. In this role he is accountable for the company’s global site strategy including building and maintaining site relationships, developing site intelligence databases, study start-up and Investigator payments. He is also responsible for supporting sites by deploying patient recruitment tactics. He started his career in the site space establishing and managing research sites and was a founder of one of the first European SMOs. He pioneered innovative patient recruitment approaches as he built a site network with a reputation for delivering high patient numbers and quality data. This included the first phase III TV advertising campaigns in the UK and some of the earliest internet based patient outreach programs. Paul joined the CRO sector in 2005 building global site networks that demonstrated outstanding delivery and continued to work on innovative patient recruitment campaigns in the most challenging environments. Since joining PAREXEL he has focused increasingly on the use of technology to both improve the efficiency of the clinical trials process and improve the experience of sites and patients. Paul is married with two grown-up children and lives in the UK.
Glenda Guest, CCRA, RQAP-GCP, TIACR has an extensive background in the clinical research industry having worked as a monitor, project manager, data management coordinator, database programmer, quality assurance auditor and senior trainer since joining the clinical research profession in 1997. She is the Vice President of Norwich Clinical Research Associates Ltd. (NCRA) a full service clinical contract research organization (CRO) based in upstate NY, USA since 1994. Through her extensive experiences in a CRO environment she’s developed a unique perspective, not only of the regulatory requirements for regulated product development and market approval, but also the insights from collaboration with multiple sponsor companies’ varying approaches in meeting those requirements. Ms. Guest is a published writer, certified clinical research associate, registered quality assurance professional (GCP) and a certified clinical research trainer. An invited speaker at local and global professional meetings, she was the recipient of ACRP’s 2015 Global Conference Top Speaker Award. Glenda is an active member of the Association of Clinical Research Professionals (ACRP), New York State MedTech Association, MAGI and the Society of Quality Assurance (SQA). She has maintained her ACRP Certified Clinical Research Associate (CCRA) status since April of 2002. She has also maintained her status through SQA as a Registered Quality Assurance Professional – Good Clinical Practices (RQAP-GCP) since April 2007. She attained Certified Trainer status (TIACR) via the International Association of Clinical Research in March 2015.
David Morin MD FACP CPI FACRP has participated as a Principal Investigator in hundreds of studies (Phase I-IV) since 1989. He attained the status of Certified Principal Investigator (CPI) in 2007 and Credentialed Clinical Research Trainer (CCRT) from the Association of Clinical Research Professionals (ACRP) in 2010. Dr. Morin received the “Outstanding Physician Leadership in the Profession” international award by ACRP and Academy of Physicians in Clinical Research (APCR) in 2012. He received his pharmacy degree with High Distinction at the University of Rhode Island, received his MD with Honors at the University of Vermont College of Medicine, and completed residency training at University of Virginia (Charlottesville). He is board certified in Internal Medicine and is a Fellow of the American College of Physicians (FACP). He joined HMG in 2008. In addition to serving as the Director of Research he provides patient care at Holston Medical Group in Kingsport, Tennessee. He served on the CPI Committee (2013-2015) and as Chair of the ACRP Awards & Recognition Committee in 2015. He is a member of the ACRP Site Strategy Group. He is a published author and has developed investigator initiated trials (IIT). Past activities include serving as a teaching attending for East Tennessee State College of Medicine, employee health director for Bristol Regional Medical Center, medical director of a pharmaceutical Contract Research Organization, pharmaceutical consultant and speaker. He co-founded several companies including Tri-Cities Medical Research and Trike, LLC which develops proprietary methodologies aimed at improving the efficiency of clinical research.
Virginia Nido, MS is an experienced leader with over 25 years of industry experience and strong competencies in drug development, business processes, team systems, and people management. She has a demonstrated ability to lead strategic projects across functions and therapeutic areas. Virginia has a wide breadth of experience in Phase II-IV clinical trials in multiple indications. Virginia is passionate about innovation in clinical research through pre-competitive industry collaborations. Virginia joined Genentech in 2002 and progressed through several roles in Product Development. Virginia did an international rotation in Basel, Switzerland in 2010, facilitating the global roll-out of molecule development teams and governance committees. Virginia is currently the global head of the Industry Collaborations group at Roche and Genentech. Virginia serves on the TransCelerate Operations Committee, the Clinical Trials Transformation Initiative Executive and Steering Committees, the Global Impact Partnership Board of the Society for Clinical Research Sites, and was formerly on the Board of Directors of the Women’s Cancer Resource Center in Oakland, CA. Before joining Genentech she worked at Quintiles, the University of California San Francisco, and the University of Pennsylvania. Virginia holds a BA from Barnard College and an MS from the University of Pennsylvania.
Ernest Prentice, PhD is the Associate Vice Chancellor for Academic Affairs at the University of Nebraska Medical Center (UNMC). He is also Professor of Genetics, Cell Biology and Anatomy and a Courtesy Professor of Public Health. Dr. Prentice is the Institutional Official for both the UNMC Human Research Protection Program and the UNMC Animal Care and Use Program. Previously he served as the Executive Chair of the UNMC Institutional Review Board (IRB) and, for over 26 years, served as the Co-Chair of the IRB. Dr. Prentice is a frequent contributor to the literature on the ethics and regulation of human research and he is a frequent speaker at meetings on various aspects of research ethics. He has given over 25 presentations at ACRP global and regional conferences and was Chair of the ACRP Education and Ethics Committees. Currently, Dr. Prentice is the Chair of the CITI Executive Advisory Board, a member of the Board of Directors for Schulman Associates IRB, and immediate past-President of the Scientists Center for Animal Welfare. From 2003-2007, he served as the Chair of the HHS Secretary’s Advisory Committee on Human Research Protection. In 2005, PRIM&R presented Dr. Prentice with the Distinguished Service Award and in 2006, the HHS OHRP presented Dr. Prentice with a medallion for Outstanding Achievement in Human Subject Protections.
SECRETARY, NON-VOTING Jim Kremidas joined ACRP as Executive Director in October 2015. Mr. Kremidas has over 30 years of experience in the health care industry, including positions in the lab, sales, marketing, strategic sourcing, and clinical operations at Eli Lilly and Company, Quintiles, inVentiv Health, and CenterWatch. While at Lilly, he led the development of the first functional area to focus on global enrollment optimization. Kremidas is a founding advisory board member at the Center for Information & Study on Clinical Research Participation and a volunteer for the Clinical Trials Transformation Initiative. Mr. Kremidas serves as non-voting Secretary to ACRP’s Board of Trustees.
We are using cookies to give you the best experience on our website.
You can find out more about which cookies we are using or switch them off in settings.
You can adjust all of your cookie settings by navigating the tabs on the left hand side.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.